Lynn Gold, PH.D.
Vice President of CMC Services
Dr. Lynn Gold has more than 25 years of experience in the pharmaceutical industry, with an extensive background in defining regulatory strategies to achieve corporate goals and moving early stage drug development programs to global regulatory submission and commercial launch. At Camargo, Gold oversees API synthesis, delivery of clinical trial materials (CTM) (formulation, manufacturing, analytical testing, packaging, stability) and the coordination of chemistry, manufacturing and controls (CMC) information into regulatory filings.
Before joining Camargo, Gold held the position of vice president of research and process development at Sonus Pharmaceuticals in Seattle and was the senior manager of pharmaceutics at Warner Chilcott Laboratories, a division of Galen Holdings in Rockaway, NJ. She holds a Ph.D. in physical organic chemistry from the University of Rochester and held a postdoctoral position at Duke University’s Department of Chemistry studying the hydrophobic control of stereochemistry.